$ORGS
Orgenesis Inc. Stock $orgs

$orgs Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223016181 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$6.975M	$7.044M	$7.212M
YoY Change	-3.14%	-2.33%	-23.19%
Cost Of Revenue	$3.232M	$2.722M	$714.0K
YoY Change	-63.69%	281.23%
Gross Profit	$3.743M	$4.322M	$6.498M
YoY Change	-320.18%	-33.49%
Gross Profit Margin	53.66%	61.36%	90.1%
Selling, General & Admin	$3.337M	$4.039M	$3.360M
YoY Change	19.05%	20.21%	21.3%
% of Gross Profit	89.15%	93.45%	51.71%
Research & Development	$3.527M	$3.281M	$6.614M
YoY Change	-9.1%	-50.39%	8.25%
% of Gross Profit	94.23%	75.91%	101.79%
Depreciation & Amortization	$597.0K	$578.0K	$474.0K
YoY Change	19.16%	21.94%	5.33%
% of Gross Profit	15.95%	13.37%	7.29%
Operating Expenses	$6.864M	$7.320M	$10.45M
YoY Change	144.88%	-29.94%	12.22%
Operating Profit	-$3.329M	-$3.205M	-$3.236M
YoY Change	-29.65%	-0.96%
Interest Expense	-$650.0K	-$645.0K	-$754.0K
YoY Change	-14.02%	-14.46%	135.63%
% of Operating Profit
Other Income/Expense, Net	-$655.0K	-$644.0K	-$6.000K
YoY Change	68.38%	10633.33%	-107.5%
Pretax Income	-$3.570M	-$4.132M	-$3.996M
YoY Change	-34.87%	3.4%	2250.59%
Income Tax	$91.00K	$129.0K	$1.000K
% Of Pretax Income
Net Earnings	-$4.127M	-$4.189M	-$4.009M
YoY Change	-23.95%	4.49%	1722.27%
Net Earnings / Revenue	-59.17%	-59.47%	-55.59%
Basic Earnings Per Share	$0.15	$0.16	$0.16
Diluted Earnings Per Share	$0.15	-$0.16	-$163.0K
COMMON SHARES
Basic Shares Outstanding	28.34M shares	27.49M shares	24.60M shares
Diluted Shares Outstanding	28.36M shares	26.48M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$180.0K	$2.674M	$1.123M
YoY Change	-92.18%	138.11%	-97.31%
Cash & Equivalents	$180.0K	$2.674M	$1.123M
Short-Term Investments
Other Short-Term Assets	$5.347M	$6.184M	$1.928M
YoY Change	327.76%	220.75%	60.67%
Inventory	$34.00K	$128.0K	$113.0K
Prepaid Expenses
Receivables	$6.000K	$37.74M	$17.08M
Other Receivables	$3.728M	$2.725M	$3.771M
Total Short-Term Assets	$9.295M	$49.45M	$24.01M
YoY Change	-63.49%	105.96%	-56.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.249M	$21.81M	$11.99M
YoY Change	-91.32%	81.88%	149.79%
Goodwill	$3.703M	$8.069M
YoY Change	-54.7%
Intangibles	$7.681M	$9.430M
YoY Change	-31.46%
Long-Term Investments	$31.48M	$136.0K	$1.574M
YoY Change	1699.09%	-91.36%	687.0%
Other Assets	$717.0K	$1.044M	$1.096M
YoY Change	-2.58%	-4.74%	-8.67%
Total Long-Term Assets	$45.47M	$43.82M	$34.53M
YoY Change	21.77%	26.9%	26.01%
TOTAL ASSETS
Total Short-Term Assets	$9.295M	$49.45M	$24.01M
Total Long-Term Assets	$45.47M	$43.82M	$34.53M
Total Assets	$54.77M	$93.27M	$58.54M
YoY Change	-12.79%	59.33%	-28.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.959M	$4.387M	$6.933M
YoY Change	-23.91%	-36.72%	-32.69%
Accrued Expenses	$2.235M	$2.510M	$3.568M
YoY Change	-46.27%	-29.65%	15.1%
Deferred Revenue		$106.0K	$70.00K
YoY Change		51.43%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.362M	$2.376M	$3.375M
YoY Change	-57.71%	-29.6%	-21.51%
Total Short-Term Liabilities	$12.71M	$13.94M	$15.25M
YoY Change	-21.75%	-8.62%	-19.3%
LONG-TERM LIABILITIES
Long-Term Debt	$17.85M	$17.37M	$7.580M
YoY Change	27.73%	129.14%	6.76%
Other Long-Term Liabilities	$60.00K	$266.0K	$848.0K
YoY Change	-77.27%	-68.63%	-34.77%
Total Long-Term Liabilities	$18.09M	$20.02M	$8.428M
YoY Change	22.98%	137.55%	0.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.71M	$13.94M	$15.25M
Total Long-Term Liabilities	$18.09M	$20.02M	$8.428M
Total Liabilities	$30.80M	$33.96M	$23.84M
YoY Change	-0.5%	42.47%	-13.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$130.0M	-$125.0M
YoY Change	12.07%
Common Stock	$154.7M	$154.7M
YoY Change	5.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.266M	$1.266M
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$23.97M	$27.67M	$34.70M
YoY Change
Total Liabilities & Shareholders Equity	$54.77M	$93.27M	$58.54M
YoY Change	-12.79%	59.33%	-28.7%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$4.127M	-$4.189M	-$4.009M
YoY Change	-23.95%	4.49%	1722.27%
Depreciation, Depletion And Amortization	$597.0K	$578.0K	$474.0K
YoY Change	19.16%	21.94%	5.33%
Cash From Operating Activities	-$5.914M	-$7.200M	-$2.792M
YoY Change	-7.8%	157.88%	-38.64%
INVESTING ACTIVITIES
Capital Expenditures	$511.0K	$1.285M	-$902.0K
YoY Change	-114.81%	-242.46%	70.19%
Acquisitions
YoY Change
Other Investing Activities	-$984.0K	-$22.00K	-$711.0K
YoY Change	-592.0%	-96.91%	7010.0%
Cash From Investing Activities	-$1.495M	-$1.307M	-$1.613M
YoY Change	-54.0%	-18.97%	198.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.886M	$5.910M	1.000K
YoY Change	-55.19%	590900.0%	-99.95%
NET CHANGE
Cash From Operating Activities	-5.914M	-$7.200M	-2.792M
Cash From Investing Activities	-1.495M	-$1.307M	-1.613M
Cash From Financing Activities	4.886M	$5.910M	1.000K
Net Change In Cash	-2.523M	-$2.597M	-4.404M
YoY Change	-303.3%	-41.03%	38.06%
FREE CASH FLOW
Cash From Operating Activities	-$5.914M	-$7.200M	-$2.792M
Capital Expenditures	$511.0K	$1.285M	-$902.0K
Free Cash Flow	-$6.425M	-$8.485M	-$1.890M
YoY Change	116.77%	348.94%	-52.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001460602
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	ORGS	Stock Issued During Period Value Issuance Of Shares Due To Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfSharesDueToExerciseOfWarrants		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2023Q1	ORGS	Proceeds From Repayment Of Convertible Loan To Related Party Partners ProceedsFromRepaymentOfConvertibleLoanToRelatedPartyPartners		usd
CY2023Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2023Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	ORGS	Issuance Of Common Stocks In Connection With Acquisition IssuanceOfCommonStocksInConnectionWithAcquisition		usd
CY2022Q1	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	ORGS	Elimination Of Acquisition Receivables EliminationOfAcquisitionReceivables		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38416
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ORGENESIS INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0583166
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20271 Goldenrod Lane
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
CY2023Q1	dei	City Area Code CityAreaCode	(480)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	659-6404
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	ORGS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28338501	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2674000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5311000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1057000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1058000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37739000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5127000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	958000	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2725000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2688000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	128000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	120000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	49450000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	46318000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	326000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	331000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	136000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	135000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21808000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22834000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9430000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9694000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2904000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2304000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	8069000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	8187000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	100000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	103000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1044000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1022000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	43817000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	44610000	usd
CY2023Q1	us-gaap	Assets Assets	93267000	usd
CY2022Q4	us-gaap	Assets Assets	90928000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4387000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4429000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2510000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2578000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	438000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	289000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1856000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1860000	usd
CY2023Q1	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	1590000	usd
CY2022Q4	ORGS	Advance Payments On Account Of Grant AdvancePaymentsOnAccountOfGrant	1578000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	106000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	62000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	60000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	675000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	542000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2314000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4504000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13938000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15910000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2148000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1728000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	17290000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	13343000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	168000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	163000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	79000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	95000	usd
CY2023Q1	ORGS	Advance Payments On Account Of Grant Non Current AdvancePaymentsOnAccountOfGrantNonCurrent	70000	usd
CY2022Q4	ORGS	Advance Payments On Account Of Grant Non Current AdvancePaymentsOnAccountOfGrantNonCurrent	144000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	266000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	271000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	20021000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15744000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	33959000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	31654000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	30305000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	30203000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	145833334	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28148110	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25832322	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27861543	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25545755	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	154691000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	150355000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-311000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	286567	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	286567	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1266000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1336000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1510000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-125450000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-121261000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	27667000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27561000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29003000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93267000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90928000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7044000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6577000	usd
CY2023Q1	us-gaap	Revenues Revenues	7044000	usd
CY2022Q1	us-gaap	Revenues Revenues	7212000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2722000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	714000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4322000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	6498000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3281000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6651000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	207000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	232000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4039000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2851000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3205000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3236000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-644000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-213000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-547000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4132000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3996000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	129000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4261000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-3997000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-72000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4189000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4009000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26246924	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24600954	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4261000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-3997000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	41000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	151000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	4302000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	4148000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	72000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	-12000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4230000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4160000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29071000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	143000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3441000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	449000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	287000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4404000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29003000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38631000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	243000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4148000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	34857000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-4261000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-3997000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	159000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	268000	usd
CY2023Q1	ORGS	Share In Net Income Of Associated Companies ShareInNetIncomeOfAssociatedCompanies	-2000	usd
CY2022Q1	ORGS	Share In Net Income Of Associated Companies ShareInNetIncomeOfAssociatedCompanies	-547000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	578000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	474000	usd
CY2023Q1	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	191000	usd
CY2022Q1	ORGS	Increase Decrease In Effect Of Exchange Differences On Intercompany Balances IncreaseDecreaseInEffectOfExchangeDifferencesOnIntercompanyBalances	2000	usd
CY2023Q1	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	47000	usd
CY2022Q1	ORGS	Net Changes In Operating Leases NetChangesInOperatingLeases	1000	usd
CY2023Q1	ORGS	Change In Interest Expenses Accrued On Loans And Convertible Loans ChangeInInterestExpensesAccruedOnLoansAndConvertibleLoans	311000	usd
CY2022Q1	ORGS	Change In Interest Expenses Accrued On Loans And Convertible Loans ChangeInInterestExpensesAccruedOnLoansAndConvertibleLoans	-147000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-283000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1613000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1917000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2183000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-340000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-59000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	554000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	69000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	468000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	138000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	36000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	10000	usd
CY2023Q1	ORGS	Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseInAdvancePaymentOnAccountOfGrant	81000	usd
CY2022Q1	ORGS	Increase Decrease In Advance Payment On Account Of Grant IncreaseDecreaseInAdvancePaymentOnAccountOfGrant	-169000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-3000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7240000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2792000	usd
CY2022Q1	ORGS	Proceeds From Repayment Of Convertible Loan To Related Party Partners ProceedsFromRepaymentOfConvertibleLoanToRelatedPartyPartners	138000	usd
CY2022Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1549000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1285000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	902000	usd
CY2022Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	702000	usd
CY2023Q1	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	22000	usd
CY2022Q1	ORGS	Repayment Of Investment In Longterm Deposits RepaymentOfInvestmentInLongtermDeposits	2000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1307000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1613000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3441000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5485000	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3000000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	16000	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	5000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5910000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2637000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4404000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6369000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5974000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3731000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1613000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	753000	usd
CY2023Q1	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	14000	usd
CY2022Q1	ORGS	Increase Decrease In Accounts Payable Related To Purchase Of Property Plant And Equipment IncreaseDecreaseInAccountsPayableRelatedToPurchaseOfPropertyPlantAndEquipment	-141000	usd
CY2022Q1	ORGS	Issuance Of Common Stocks In Connection With Acquisition IssuanceOfCommonStocksInConnectionWithAcquisition	100000	usd
CY2023Q1	ORGS	Extinguishment In Connection With Convertible Loan Restructuring ExtinguishmentInConnectionWithConvertibleLoanRestructuring	287000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	785000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-125000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7200000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zMJcsfIvbyXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zSvcrBWa7SS8">Use of Estimates in the Preparation of Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of our consolidated financial statements in conformity with U.S. GAAP requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, judgments, and methodologies. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity, the amount of revenues and expenses and determining whether an acquisition is a business combination or a purchase of asset. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zBDbRTec9YWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zqOoNMEO60s2">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to the prior year’s financial statements to conform to the current year presentation. These reclassifications had no net effect on previously reported results of operations.</span></p>
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-4189000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4009000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26246924	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24600954	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023Q1	us-gaap	Revenues Revenues	7044000	usd
CY2022Q1	us-gaap	Revenues Revenues	7212000	usd
CY2023Q1	ORGS	Schedule Of Breakdown Of Revenues Per Customer ScheduleOfBreakdownOfRevenuesPerCustomer	<p id="xdx_898_ecustom--ScheduleOfBreakdownOfRevenuesPerCustomer_zj4rIHEZu7Ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A breakdown of the revenues per customer constituted at least 10% of revenues is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zQ0Fw8NolJE5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BREAKDOWN OF REVENUES PER CUSTOMER</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Revenue earned:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: justify">Customer A (United States)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerAMember_zfPNfN7Gcob3" style="width: 16%; text-align: right" title="Customer A (Greece)">3,605</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerAMember_z0YnjfuzBEMg" style="width: 16%; text-align: right" title="Customer A (Greece)">1,226</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer B (Greece)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerBMember_zxUxW9qM3DPd" style="text-align: right" title="Customer B (China)">2,022</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerBMember_zdItUNVqTp3j" style="text-align: right" title="Customer B (China)">661</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C (United States)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerCMember_zcmXcKtKkLCl" style="text-align: right" title="Revenue earned">750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerCMember_zy1c3J0lUDrj" style="text-align: right" title="Revenue earned"><span style="-sec-ix-hidden: xdx2ixbrl0889">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Customer D (Korea)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerDMember_z9a3H0Ip0imj" style="text-align: right" title="Revenue earned"><span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerDMember_z1vWBSCNkxnl" style="text-align: right" title="Revenue earned">2,683</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer E (United Arab Emirates)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerEMember_zj2bgSMVTjsb" style="text-align: right" title="Revenue earned"><span style="-sec-ix-hidden: xdx2ixbrl0895">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3n3_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerEMember_z2EbCVizz4Da" style="text-align: right" title="Revenue earned">1,067</td><td style="text-align: left"> </td></tr> </table>
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36183000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15245000	usd
CY2022Q1	ORGS	Elimination Of Acquisition Receivables EliminationOfAcquisitionReceivables	-1337000	usd
CY2023Q1	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	7057000	usd
CY2022Q1	ORGS	Accounts Receivable Additions AccountsReceivableAdditions	7249000	usd
CY2023Q1	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-5454000	usd
CY2022Q1	ORGS	Accounts Receivable Collections AccountsReceivableCollections	-4042000	usd
CY2023Q1	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-47000	usd
CY2022Q1	ORGS	Exchange Rate Differences Of Accounts Receivable ExchangeRateDifferencesOfAccountsReceivable	-40000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37739000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17075000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	59000	usd
CY2023Q1	ORGS	Contract With Customer Liability Addition ContractWithCustomerLiabilityAddition	36000	usd
CY2022Q1	ORGS	Contract With Customer Liability Addition ContractWithCustomerLiabilityAddition	11000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	106000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	70000	usd
CY2023Q1	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	the plaintiffs are seeking that the Court issue a declaratory remedy whereby the defendants are required to pay royalties to the plaintiffs at the rate of 7% of the sales and 24% of any and all revenues in consideration for sublicenses related to any product, service or process that contain know-how and technology of Sheba and any and all know-how and technology either developed or supervised by Prof. Ferber in the field of cell therapy, including in the category of the point-of-care platform and any and all services and products in relation to the defendants’ CDMO activity.
CY2022Q1	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	10000000

Files In Submission

Name	View Source	Status
0001493152-23-016181-index-headers.html	Edgar Link	pending
0001493152-23-016181-index.html	Edgar Link	pending
0001493152-23-016181.txt	Edgar Link	pending
0001493152-23-016181-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgs-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
orgs-20230331_cal.xml	Edgar Link	unprocessable
orgs-20230331_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
orgs-20230331_lab.xml	Edgar Link	unprocessable
orgs-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGS
Orgenesis Inc. Stock $orgs

2023 Q2 Form 10-Q Financial Statement

#000149315223016181 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS Orgenesis Inc. Stock $orgs

2023 Q2 Form 10-Q Financial Statement

#000149315223016181 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGS
Orgenesis Inc. Stock $orgs